HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Shortness of breath: an uncommon side-effect of cyproterone acetate in the treatment of androgenetic alopecia.

Abstract
Cyproterone acetate is indicated for treatment of acne, hirsutism, seborrhea, and androgenetic alopecia in females. In general this medication is well tolerated in standard doses. Shortness of breath has been previously reported in men with prostatic carcinoma, receiving high-dose (200 mg/day) treatment with cyproterone acetate. We report a 66-year-old lady taking 50 mg/day of cyproterone acetate for biopsy proven androgenetic alopecia, who developed this unusual complication of shortness of breath. To our knowledge it has not been previously reported in women undergoing treatment for androgenization.
AuthorsRica Mallari, Rodney D Sinclair
JournalInternational journal of dermatology (Int J Dermatol) Vol. 41 Issue 12 Pg. 946-7 (Dec 2002) ISSN: 0011-9059 [Print] England
PMID12492998 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Androgen Antagonists
  • Cyproterone Acetate
Topics
  • Aged
  • Alopecia (drug therapy)
  • Androgen Antagonists (adverse effects, therapeutic use)
  • Cyproterone Acetate (adverse effects, therapeutic use)
  • Dyspnea (chemically induced)
  • Female
  • Humans

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: